Mum’s plea: ‘I’m dying but $7.70 could save my kids’

10 April 2024 - Amelia Ramsay has battled all her life – and now she may have to watch her kids ...

Read more →

Cheaper medicines for advanced melanoma and multiple sclerosis

5 February 2024 - From 1 February 2024, Australians with advanced melanoma and relapsing-remitting multiple sclerosis will have access to ...

Read more →

Outcomes from the December 2023 PBAC intracycle meeting

25 January 2024 - The outcomes from the December 2023 PBAC intracycle meeting are now available. ...

Read more →

AstraZeneca cancer drug Calquence cost tumbles with PBS listing

23 December 2023 - An AstraZeneca drug’s listing on the PBS from January 1 will see bills fall massively for people ...

Read more →

Keytruda is a step closer to being available for more cancers listed on the PBS

1 December 2023 - Thousands of cancer patients in Australia will benefit from a major change that would see Keytruda offered ...

Read more →

New treatment for advanced prostate cancer added to the PBS

16 November 2023 - Prostate cancer is one of the most commonly diagnosed cancer in Australia. ...

Read more →

New treatment for women battling aggressive breast cancer

6 November 2023 - Women diagnosed with an aggressive form of breast cancer will have access to new treatment through the ...

Read more →

New drug on PBS offers hope for women with aggressive breast cancer

5 November 2023 - A cutting-edge breast cancer drug has been added to the PBS for women with an especially ...

Read more →

Launch of the Australian Cancer Plan

2 November 2023 - Learn about the new Australian Cancer Plan, which aims to improve prevention, screening, treatment and management of ...

Read more →

Expanded medicines for breast cancer and leukaemia on the PBS

26 September 2023 - From 1 September 2023, Australians with an aggressive form of breast cancer and certain types of leukaemia ...

Read more →

Review of cancer related surrogate outcomes used for PBAC decision-making

8 September 2023 - Surrogate outcome measures have an increasingly important role in cancer medicine research providing evidence to support ...

Read more →

Efficient Funding of Chemotherapy Review – final report

28 August 2023 - The final report of the Efficient Funding of Chemotherapy Review is now available. ...

Read more →

Estimating overall survival in people receiving PBS listed cancer medicines in Australian clinical practice

18 August 2023 - In September 2021, the Department of Health and Aged Care contracted the Medicines Intelligence Centre for ...

Read more →

New treatments for people with chronic migraine and soft tissue sarcoma added to the PBS

14 August 2023 - From August 2023, Australians with chronic migraine and soft tissue sarcoma will have access to new ...

Read more →

Global sarcoma therapy now listed on Pharmaceutical Benefits Scheme

31 July 2023 - Yondelis (trabectedin) demonstrates 45% reduction in risk of disease progression or death versus dacarbazine. ...

Read more →